Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

UCH-L4 Activators

UCH-L4 Activators encompass a group of compounds that indirectly enhance the functional activity of the ubiquitin carboxyl-terminal hydrolase L4 (UCH-L4), which is involved in processing ubiquitin precursors and ubiquitinated proteins to regulate protein degradation. These activators typically work by inhibiting other deubiquitinating enzymes (DUBs) or elements of the ubiquitin-proteasome system (UPS), leading to an increased pool of ubiquitinated proteins. As UCH-L4 is tasked with trimming ubiquitin chains from these proteins, an increase in ubiquitinated substrates inherently necessitates enhanced activity of UCH-L4 to maintain cellular protein homeostasis.

The biochemical landscape that UCH-L4 activators influence is characterized by a complex interplay of enzymes that attach and remove ubiquitin tags from proteins to dictate their fate within the cell. By inhibiting other DUBs or elements of the UPS, these activators create a cellular environment rich in ubiquitin-protein conjugates. This ubiquitin-rich milieu drives the demand for UCH-L4's hydrolase activity as the cell strives to recycle ubiquitin and regulate protein degradation processes. As such, the indirect activation of UCH-L4 through these compoundsis achieved by a shift in the equilibrium of ubiquitin-protein conjugates, rather than by direct binding or allosteric modulation of UCH-L4 itself.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IU1

314245-33-5sc-361215
sc-361215A
sc-361215B
10 mg
50 mg
100 mg
$138.00
$607.00
$866.00
2
(0)

A selective inhibitor of USP14, a deubiquitinating enzyme, which can lead to an accumulation of polyubiquitinated proteins and potentially enhance the activity of UCH-L4 as it works to process and trim these chains.

P005091

882257-11-6sc-478535
10 mg
$155.00
(0)

A selective inhibitor of USP7, leading to the accumulation of ubiquitin-protein conjugates that could enhance the functional activity of UCH-L4 by providing more substrates for it to act upon.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An irreversible inhibitor of ubiquitin-activating enzyme E1, leading to decreased ubiquitin conjugation and potentially increasing the relative activity of deubiquitinating enzymes like UCH-L4 to maintain cellular ubiquitin homeostasis.